These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37476923)

  • 21. Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis.
    Luo D; Mei B; Wang P; Li X; Chen X; Wei G; Kuang F; Li B; Su S
    Clin Microbiol Infect; 2024 Mar; 30(3):328-335. PubMed ID: 37866679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent symptoms after COVID-19 in children and adolescents from Argentina.
    Seery V; Raiden S; Penedo JMG; Borda M; Herrera L; Uranga M; Marcó Del Pont M; Chirino C; Erramuspe C; Alvarez LS; Lenoir M; Morales LD; Davenport C; Huespe Auchter S; Monsalvo L; Sastoque L; Gavazzi M; Russo C; Sananez I; Pando MLÁ; Laufer N; Muiños R; Ferrero F; Geffner J; Arruvito L
    Int J Infect Dis; 2023 Apr; 129():49-56. PubMed ID: 36736574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptoms compatible with long COVID in an Italian pediatric cohort of Tourette patients with and without SARS‑CoV‑2 infection: a short-term follow-up assessment.
    Prato A; Salerno AM; Saia F; Maugeri N; Zanini A; Scerbo M; Barone R; Rizzo R
    BMC Pediatr; 2023 May; 23(1):222. PubMed ID: 37147589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review.
    Müller SA; Isaaka L; Mumm R; Scheidt-Nave C; Heldt K; Schuster A; Abdulaziz M; El Bcheraoui C; Hanefeld J; Agweyu A
    Lancet Glob Health; 2023 Nov; 11(11):e1713-e1724. PubMed ID: 37858583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric COVID-19: Systematic review of the literature.
    Patel NA
    Am J Otolaryngol; 2020; 41(5):102573. PubMed ID: 32531620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
    Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
    JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colchicine for the treatment of COVID-19.
    Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
    Whittaker E; Bamford A; Kenny J; Kaforou M; Jones CE; Shah P; Ramnarayan P; Fraisse A; Miller O; Davies P; Kucera F; Brierley J; McDougall M; Carter M; Tremoulet A; Shimizu C; Herberg J; Burns JC; Lyall H; Levin M;
    JAMA; 2020 Jul; 324(3):259-269. PubMed ID: 32511692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.
    Molteni E; Sudre CH; Canas LS; Bhopal SS; Hughes RC; Antonelli M; Murray B; Kläser K; Kerfoot E; Chen L; Deng J; Hu C; Selvachandran S; Read K; Capdevila Pujol J; Hammers A; Spector TD; Ourselin S; Steves CJ; Modat M; Absoud M; Duncan EL
    Lancet Child Adolesc Health; 2021 Oct; 5(10):708-718. PubMed ID: 34358472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
    Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
    Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Imaging in Newborns, Children and Adolescents Infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Is There a Realistic Alternative to Lung High-Resolution Computed Tomography (HRCT) and Chest X-Rays? A Systematic Review of the Literature.
    Caroselli C; Blaivas M; Falzetti S
    Ultrasound Med Biol; 2021 Nov; 47(11):3034-3040. PubMed ID: 34429231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long COVID in pediatrics-epidemiology, diagnosis, and management.
    Toepfner N; Brinkmann F; Augustin S; Stojanov S; Behrends U
    Eur J Pediatr; 2024 Apr; 183(4):1543-1553. PubMed ID: 38279014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the COVID-19 pandemic on children and young people.
    Magklara K; Kyriakopoulos M
    Psychiatriki; 2023 Dec; 34(4):265-268. PubMed ID: 37982248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long COVID prevalence, risk factors and impact of vaccination in the paediatric population: A survey study in Singapore.
    Li J; Nadua K; Chong CY; Yung CF
    Ann Acad Med Singap; 2023 Oct; 52(10):522-532. PubMed ID: 38920203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 38. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
    Rostami A; Sepidarkish M; Leeflang MMG; Riahi SM; Nourollahpour Shiadeh M; Esfandyari S; Mokdad AH; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Mar; 27(3):331-340. PubMed ID: 33228974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.